Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Posters

Posters

  • Wednesday, October 2, 2024
  • 10:30 AM - 11:45 AM ET
    3597 - Dosimetric Evaluation of Organs-at-Risk and Quality of Life Assessment between Standard of Care and Dose De-Escalated Radiation in HPV Positive Oropharyngeal Cancer
    Location: Hall C
    Presenter: Amy Abdalla, MD – University of Missouri - Ellis Fischel Cancer Center
  • 10:30 AM - 11:45 AM ET
    3598 - Early Recurrence in Patients Treated with Surgical Resection and Postoperative Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
    Location: Hall C
    Presenter: Khaled Abumansour, MBBS – Dalhousie University
  • 10:30 AM - 11:45 AM ET
    3599 - Outcomes of Curatively Treated De Novo Metastatic Nasopharyngeal Carcinoma: A Single Institution Experience
    Location: Hall C
    Presenter: Mohammed Almahmoud, MBBS – King Faisal Specialist Hospital and Research Centre
  • 10:30 AM - 11:45 AM ET
    3600 - Less is More: Long Term Gastrostomy Tube Dependence in Head and Neck Cancer
    Location: Hall C
    Presenter: Neil Almeida, MD – Roswell Park Comprehensive Cancer Center
  • 10:30 AM - 11:45 AM ET
    3601 - Lymphopenia During Radiotherapy in Nasopharyngeal Cancer: Identifying Patients at Risk and Its Effect on Survival
    Location: Hall C
    Presenter: Faisal Alsamari, MBBS – King Faisal Specialist Hospital and Research Centre
  • 10:30 AM - 11:45 AM ET
    3602 - Outcomes of Stage I Single Node HPV Positive Oropharynx Cancer
    Location: Hall C
    Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
  • 10:30 AM - 11:45 AM ET
    3603 - The Use of a Low Dose Elective Volume in Head and Neck Stereotactic Body Radiation Therapy (SBRT): Initial Report of Outcomes of a Novel Planning Approach
    Location: Hall C
    Presenter: Katherine Amarell, MD, BS – Cleveland Clinic Foundation
  • 10:30 AM - 11:45 AM ET
    3604 - Medical Physics Teleradiotherapy Quality Assurance (QA) Capacity in Low- and Middle-Income Countries (LMICs): An International Survey
    Location: Hall C
    Presenter: August Anderson, MD – University of Washington
  • 10:30 AM - 11:45 AM ET
    3605 - "Big Jolts Like an Electric Shock:" Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer
    Location: Hall C
    Presenter: Maheen Ansari, BS – MD Anderson Cancer Center
  • 10:30 AM - 11:45 AM ET
    3606 - Climate-Smart Oncology: Can Hypofractionation Lighten Radiotherapys Environmental Load?
    Location: Hall C
    Presenter: Alyssa Asaro, MS, BA – St. George's University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3607 - Independent Review Organization and Proton Therapy: Multi-State Analysis and Legal Procedural Strategies
    Location: Hall C
    Presenter: Etzer Augustin, MD, MS – UF Health Radiation Oncology – Davis Cancer Pavilion
  • 10:30 AM - 11:45 AM ET
    3608 - The Impact of Circulating Tumor Human Papillomavirus (HPV) DNA Clearance Kinetics on Disease Outcomes during Chemoradiation in Patients with HPV-Associated Oropharyngeal Cancer
    Location: Hall C
    Presenter: Sujith Baliga, MD – The Ohio State University
  • 10:30 AM - 11:45 AM ET
    3609 - FIERCE-HN: A Multicenter, Randomized, Placebo-Controlled, Phase 3 Study of Ficlatuzumab + Cetuximab in Pts W/ Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
    Location: Hall C
    Presenter: Julie Bauman, MD – George Washington University Cancer Center
  • 10:30 AM - 11:45 AM ET
    3610 - The Role of Mouthguard Customization to Minimize Risk of Radiation Backscatter in Head and Neck Cancer Patients
    Location: Hall C
    Presenter: Idil Bilgen, MD, MD(c) – Koc University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3611 - A Pilot, First in Human Study of Autologous IFN-Gamma Stimulated Mesenchymal Stromal Cells for Treatment of Radiation-Induced Xerostomia - Results of Contralateral Injections
    Location: Hall C
    Presenter: Randall Kimple, MD, PhD, MBA, FASTRO – Univ of Wisconsin
  • 10:30 AM - 11:45 AM ET
    3612 - Proton Beam Radiotherapy with Fixed Beam Chair-Based Delivery System for Locally Recurrent Head and Neck and Brain Malignancies
    Location: Hall C
    Presenter: Philip Blumenfeld, MD, MPH – Hadassah Medical Center
  • 10:30 AM - 11:45 AM ET
    3613 - Predicting 12-Month Post-Treatment Aspiration for Oropharyngeal Squamous Cell Cancer Patients
    Location: Hall C
    Presenter: Aaron Bogan, MA – Mayo Clinic
  • 10:30 AM - 11:45 AM ET
    3614 - Adjuvant Ruthenium Plaque Brachytherapy (BRT) after Partial Lamellar Vitreo-Uvectomy (PLSU) for Medium-Large Uveal Melanoma (UM)
    Location: Hall C
  • 10:30 AM - 11:45 AM ET
    3615 - Definitive and Salvage Stereotactic Body Radiation Therapy (SBRT) for Nonmelanoma Skin Cancer of the Head and Neck
    Location: Hall C
    Presenter: Lindsey Callier, MS – Ohio University Heritage College of Osteopathic Medicine
  • 10:30 AM - 11:45 AM ET
    3616 - Commensal Bacteria Modulate the Immune Response to Radiation Therapy (RT) in a Murine Oral Cavity Model
    Location: Hall C
    Presenter: Elvin Canseco, BS – Cedars-Sinai Medical Center
  • 10:30 AM - 11:45 AM ET
    3617 - Assessing Clinical and Dosimetric Benefits of Spot-Scanning Proton Arc Therapy in Ocular Melanoma Treatment
    Location: Hall C
    Presenter: Xi Cao, MD – William Beaumont Hospital
  • 10:30 AM - 11:45 AM ET
    3618 - Region and Language Centric, Virtual Education and Training in Latin America: Stereotactic Body Radiotherapy and Radiosurgery Curriculum in Spanish for Medical Physicists and Radiation Oncologists
    Location: Hall C
    Presenter: Serguei Castaneda, MD – CB Oncology Partners
  • 10:30 AM - 11:45 AM ET
    3619 - Determinants of Chemosensory Dysfunction after Treatment for Nasopharyngeal Carcinoma: A Multi-Institutional Prospective Cohort Study
    Location: Hall C
    Presenter: Annie Chan, MD – Massachusetts General Hospital
  • 10:30 AM - 11:45 AM ET
    3620 - Parotid Voxel Dose Analysis with Machine Learning Toward Xerostomia Prediction in Head and Neck Cancer Irradiation
    Location: Hall C
    Presenter: Ming Chao, PhD – Icahn School of Medicine at Mount Sinai
  • 10:30 AM - 11:45 AM ET
    3621 - Detection of Oligo-Metastases in Oropharyngeal Carcinoma Following (Chemo)Radiation Therapy
    Location: Hall C
    Presenter: Revadhi Chelvarajah, MBBS – Princess Margaret Cancer Center
  • 10:30 AM - 11:45 AM ET
    3622 - Outcomes and Characteristics of Patients Receiving Pre-Operative vs. Post-Operative Radiotherapy for Sinonasal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Revadhi Chelvarajah, MBBS – Princess Margaret Cancer Center
  • 10:30 AM - 11:45 AM ET
    3623 - Prognostic Significance of Dynamics in Pan-Immune-Inflammation Value in Patients with Head and Neck Cancer Treated with Radiotherapy: Results from a Large Cohort Study
    Location: Hall C
    Presenter: Hsiang Ting Chen, MD – Linkou Chang Gung Memorial Hospital
  • 10:30 AM - 11:45 AM ET
    3624 - The Correlation Study of Circadian Clock Gene Bmal1 on Growth Inhibition and Radiosensitivity in Subcutaneous Xenograft of Human Nasopharyngeal Carcinoma CNE1 in Nude Mice
    Location: Hall C
    Presenter: Yue Chen, MS, MBBS – The Affiliated Cancer Hospital of Guizhou Medical University
  • 10:30 AM - 11:45 AM ET
    3625 - Massive Nasal Bleeding in Patients with Nasopharyngeal Carcinoma Received Curative Radiotherapy
    Location: Hall C
    Presenter: Hao-Shen Cheng, MD – Taichung Veterans General Hospital
  • 10:30 AM - 11:45 AM ET
    3626 - Perception and Use of Medical Cannabis in Head and Neck Cancer
    Location: Hall C
    Presenter: Jennifer Chiang, MD, MS – Stanford Health Care
  • 10:30 AM - 11:45 AM ET
    3627 - Safety and Activity Profile of Fianlimab (Anti-LAG-3) in Combination With Cemiplimab (Anti-PD-1) and Cemiplimab Monotherapy in Recurrent and/or Metastatic HNSCC
    Location: Hall C
    Presenter: John Kaczmar, MD – Hollings Cancer Center
  • 10:30 AM - 11:45 AM ET
    3628 - Ptcog International Survey of Practice Patterns and Trends in Utilization of Proton Therapy for Breast Cancer
    Location: Hall C
    Presenter: Isabelle Choi, MD – New York Proton Center
  • 10:30 AM - 11:45 AM ET
    3629 - Long-Term Results of External Beam Radiation Therapy (RT) with or without Concurrent Chemotherapy in Loco-Regionally Advanced or Recurrent Differentiated Thyroid Cancer (DTC)
    Location: Hall C
    Presenter: Justin Choi, M.Ed. – SUNY Downstate College of Medicine
  • 10:30 AM - 11:45 AM ET
    3630 - Resource Implications of Evolving Breast Cancer Radiotherapy Treatment Protocols
    Location: Hall C
    Presenter: Daniel Coyle, MB, ChB, BAO, PgCert – Royal College of Surgeons in Ireland
  • 10:30 AM - 11:45 AM ET
    3631 - Clinical Parameters Associated with Carotid Artery Stenosis and Stroke Following Neck Radiotherapy
    Location: Hall C
    Presenter: Susanna D'Silva, BS – University of Virginia School of Medicine
  • 10:30 AM - 11:45 AM ET
    3632 - Trajectory of Geriatric Assessment and Quality of Life in Older Adults Undergoing Definitive Treatment for Head and Neck Cancer: A Pilot Study
    Location: Hall C
    Presenter: Ryan Davis, MD – City of Hope National Medical Center
  • 10:30 AM - 11:45 AM ET
    3633 - Radiotherapy in Interventional Clinical Trials in Cancer: The Role of Radiation Oncologists and Medical Physicists
    Location: Hall C
    Presenter: Kujtim Latifi, PhD – Moffitt Cancer Center
  • 10:30 AM - 11:45 AM ET
    3634 - Development of a Radiation Oncology Fee Schedule Model for Industry-Sponsored Clinical Trials
    Location: Hall C
    Presenter: Kujtim Latifi, PhD – Moffitt Cancer Center
  • 10:30 AM - 11:45 AM ET
    3635 - Nasopharynx Cancer in the U.S.: Disparities in Stage at Presentation
    Location: Hall C
    Presenter: Edward Dee, MD – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3636 - Nasopharynx Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality
    Location: Hall C
    Presenter: Edward Dee, MD – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3637 - HPV-DNA Titers and Tumor Volume Correlation in Human Papillomavirus Related Oropharyngeal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University
  • 10:30 AM - 11:45 AM ET
    3638 - Individualized Thyroid Prescriptions Based on a Novel Tolerance Dose Model for Radiation-Induced Hypothyroidism in Nasopharyngeal Carcinoma Patients
    Location: Hall C
    Presenter: Jianming Ding, MD – Fujian Cancer Hospital
  • 10:30 AM - 11:45 AM ET
    3639 - Comparative Performance of ctHPVDNA and Imaging Surveillance for Oropharyngeal Cancer Following Radiotherapy
    Location: Hall C
    Presenter: Yifu Ding, MD, PhD – Winship Cancer Institute of Emory University
  • 10:30 AM - 11:45 AM ET
    3640 - Treatment Planning Workflow and Perceptions about Automated Contouring and Treatment Planning in Africa
    Location: Hall C
    Presenter: Michael Dykstra, MD – University of Michigan
  • 10:30 AM - 11:45 AM ET
    3641 - CT Simulator Downtime in Africa: Survey Results from AORTIC 2023
    Location: Hall C
    Presenter: Michael Dykstra, MD – University of Michigan
  • 10:30 AM - 11:45 AM ET
    3642 - The Utility of Google Maps in Measuring Radiotherapy Travel Burden in LMICs: Perspectives from the Philippines
    Location: Hall C
    Presenter: Michelle Ann Eala, MD – UCLA David Geffen School of Medicine/UCLA Medical Center
  • 10:30 AM - 11:45 AM ET
    3643 - Quantification of Temporal Cytopenic Changes during Concurrent Head and Neck Chemoradiation
    Location: Hall C
    Presenter: Sasha Ebrahimi, MD, PhD – UCLA Radiation Oncology
  • 10:30 AM - 11:45 AM ET
    3644 - Radiotherapy (RT) Treatment Patterns Among Patients Treated Definitively for Primary Breast Cancer at a Major Cancer Center in Rwanda
    Location: Hall C
    Presenter: Keara English, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 10:30 AM - 11:45 AM ET
    3645 - Choroidal Metastasis in the Systemic Targeted Therapy Era
    Location: Hall C
    Presenter: Moses Evbuomwan, MD, MBA, MPH, MA – University of Iowa Hospitals & Clinics
  • 10:30 AM - 11:45 AM ET
    3646 - Psychosocial Factors Affecting Cancer Patients Undergoing Radiation Therapy in Lagos, Nigeria
    Location: Hall C
    Presenter: Moses Evbuomwan, MD, MBA, MPH, MA – University of Iowa Hospitals & Clinics
  • 10:30 AM - 11:45 AM ET
    3647 - Oral Cavity Carcinoma with Persistent or Rapidly Progressive Disease after Surgical Resection: Outcomes of Additional Therapy
    Location: Hall C
    Presenter: David Buchberger, MD, MSc – Cleveland Clinic Foundation
  • 10:30 AM - 11:45 AM ET
    3648 - Osteoradionecrosis Incidence in Oral Cavity Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Alyssa Farley, MD – University of Cincinnati - Barrett Cancer Center
  • 10:30 AM - 11:45 AM ET
    3649 - Understanding Current Processes of Multidisciplinary Collaboration in Radiation Oncology Treatment Planning and Follow-Up across NCORP Network Practices
    Location: Hall C
    Presenter: Michael Farris, MD – Wake Forest University Medical Center
  • 10:30 AM - 11:45 AM ET
    3650 - A Retrospective Study of Outcomes of Patients with Pleomorphic Dermal Sarcoma Receiving Adjuvant Radiotherapy
    Location: Hall C
    Presenter: Harith Fernando, MD – Peter MacCallum Cancer Institute
  • 10:30 AM - 11:45 AM ET
    3651 - Clinical and Dosimetric Factors Associated with Reactive Gastrostomy Tube Placement in Patients Treated with Radiotherapy for Head and Neck Cancer
    Location: Hall C
    Presenter: Nicholas Gallardo, BS – Wake Forest University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3652 - Patterns of FDA Approval for Novel Oncology Drugs
    Location: Hall C
    Presenter: Yevgeniy Gladkiy, MS – Wright State University
  • 10:30 AM - 11:45 AM ET
    3653 - Forecasted Global Brachytherapy Shortfall by 2040: Investments Needed to Overcome this Deficit
    Location: Hall C
    Presenter: Andre Gouveia, MD – McMaster University
  • 10:30 AM - 11:45 AM ET
    3654 - Multicenter Phase III Trial of Chemoradiation (CRT) with IMPT vs. IMRT for Oropharyngeal Squamous Cell Carcinoma (OPSCC): Secondary Analysis of Association of Lymphopenia with Treatment Modality, Emer
    Location: Hall C
    Presenter: Adam Grippin, MD, PhD – MD Anderson Cancer Center
  • 10:30 AM - 11:45 AM ET
    3655 - Stereotactic Body Radiotherapy with Tyrosine Kinase Inhibitors for Refractory Locoregional Progression of Non-Anaplastic Thyroid Cancer
    Location: Hall C
    Presenter: Bin Gui, MD, MS – Northwell Health
  • 10:30 AM - 11:45 AM ET
    3656 - Clinical Outcomes after Dose De-Escalation for Prophylactic Nodal Irradiation in Nasopharyngeal Carcinoma: A Long-Term, Single-Center Experience
    Location: Hall C
    Presenter: Qiaojuan Guo, MD, PhD – Fujian Medical University Oncology Hospital
  • 10:30 AM - 11:45 AM ET
    3657 - Refining the Radiologic Criteria of Parotid Node Groups Metastasis in Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Qiaojuan Guo, MD, PhD – Fujian Medical University Oncology Hospital
  • 10:30 AM - 11:45 AM ET
    3658 - Dosimetric Predictors of Hypothyroidism after Combined Modality Therapy ± Immunotherapy for HPV-Related Oropharyngeal Cancer: A Secondary Analysis of Prospective Trials
    Location: Hall C
    Presenter: Michael Gutman, MD – University of Chicago
  • 10:30 AM - 11:45 AM ET
    3659 - Examining Rectal Spacer Use in Prostate Cancer Radiation Therapy by Treatment Modality: Insights from Medicare Claims Data
    Location: Hall C
    Presenter: Ryan Hankins, MD – Medstar Georgetown University Hospital
  • 10:30 AM - 11:45 AM ET
    3660 - Evaluation of Adjuvant Chemotherapy after Induction Chemotherapy and Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Propensity Score-Matched Analysis
    Location: Hall C
    Presenter: Yan He, PhD
  • 10:30 AM - 11:45 AM ET
    3662 - Multi-Sequence MRI Based Metachronous Single-Organ Metastasis Prediction of Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Peng Zhang, MD – Sichuan Cancer Hospital and Institute
  • 10:30 AM - 11:45 AM ET
    3663 - Predicting the Risk of Local Failure after Treatment for Head and Neck Squamous Cell Carcinoma Using Clinical and Post-Radiotherapy PET/CT Imaging Features
    Location: Hall C
    Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3664 - Evaluation of a Novel Prognostic System for Overall Survival in Surgically Resected Oral Cavity Carcinoma
    Location: Hall C
    Presenter: Zain Husain, MD – Southern California Permanente Medical Group
  • 10:30 AM - 11:45 AM ET
    3665 - Impact of Depth of Invasion on Locoregional Failure in RTOG 0920-Eligible Early-Stage Oral Tongue Squamous Cell Carcinoma and Implications for Adjuvant Therapy
    Location: Hall C
    Presenter: Onita Bhattasali, MD, MPH – Kaiser Permanente Los Angeles Medical Center
  • 10:30 AM - 11:45 AM ET
    3666 - Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Carl Jay Jainar, MD – University of Santo Tomas Hospital, Benavides Cancer Institute
  • 10:30 AM - 11:45 AM ET
    3667 - Effect of Time-of-Day Nivolumab and Stereotactic Body Radiotherapy in Metastatic Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Prospective Randomized Trial
    Location: Hall C
    Presenter: James Janopaul-Naylor, MD – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3668 - Radiomic Correlates of Mandibular Osteoradionecrosis after Radiation Treatment of Head and Neck Cancer Patients
    Location: Hall C
    Presenter: Abdallah Mohamed, MD, PhD – Baylor College of Medicine
  • 10:30 AM - 11:45 AM ET
    3669 - Prognosis of p16 and HPV Discordant Oropharyngeal Cancers: Natural Language Processing to Classify Free-Text Pathology Reports
    Location: Hall C
    Presenter: Jung Kang, MD, PhD – Yale University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3670 - The Geriatric 8 Score is Associated with Determination of Treatment Strategy and Survival Outcomes for Curative Radiotherapy of Head and Neck Cancer in the Elderly
    Location: Hall C
    Presenter: Tsuyoshi Katsuta, MD, PhD – Hiroshima University
  • 10:30 AM - 11:45 AM ET
    3671 - The Impact of National Holidays on Postoperative Radiotherapy of Squamous Cell Carcinoma of the Head and Neck
    Location: Hall C
    Presenter: Michael Kim, MD, BS – University of California Los Angeles
  • 10:30 AM - 11:45 AM ET
    3672 - Radiotherapy Under the Falling Bombs: Lessons from Ukraine
    Location: Hall C
    Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
  • 10:30 AM - 11:45 AM ET
    3673 - Overall Survival of Anaplastic Thyroid Carcinoma in the Molecular Era
    Location: Hall C
    Presenter: Shreya Kuchipudi, BA – Washington University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3674 - A Survival Analysis of Patients with Radiation-Induced Cancers after Prior Radiation for Head and Neck Cancer
    Location: Hall C
    Presenter: Eyiwunmi Laseinde, BA – Stanford University
  • 10:30 AM - 11:45 AM ET
    3675 - Cost Estimates of Brachytherapy Delivery in Northern Tanzania Using Time-Driven Activity Based Costing
    Location: Hall C
    Presenter: Jim Leng, MD – Duke University
  • 10:30 AM - 11:45 AM ET
    3677 - Long Term Outcomes of Adjuvant Radiation in Early-Stage Breast Cancer Women with 65 Years or Older after Breast-Conserving Surgery
    Location: Hall C
    Presenter: Shih-min Lin, MD – Chang Gung Memorial Hospital
  • 10:30 AM - 11:45 AM ET
    3678 - Preliminary Evaluation of HyperArc Stereotactic Body Radiotherapy for Local Recurrent Nasopharyngeal Cancer: Do Dosimetric Advantages Translate into Therapeutic Benefits?
    Location: Hall C
    Presenter: Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital
  • 10:30 AM - 11:45 AM ET
    3679 - CT-Based Radiomic Biomarkers for Predicting Progression-Free Survival in Head and Neck Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Lei Ren, PhD – University of Maryland Radiation Oncology
  • 10:30 AM - 11:45 AM ET
    3680 - Development and Validation of a Clinical-Radiomics Model to Predict Distant Metastasis in Non-Endemic Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Changhao Liu – Xijing Hospital
  • 10:30 AM - 11:45 AM ET
    3681 - Long Term Outcomes And Late Toxicity of Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting Radiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized,
    Location: Hall C
    Presenter: Feng Liu, MD – Hunan Cancer Hospital
  • 10:30 AM - 11:45 AM ET
    3682 - Compare the Predictive Performance of Deep Learning and Radiomics Models for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Junyi Liu, MB
  • 10:30 AM - 11:45 AM ET
    3685 - Association of Weekly Cisplatin vs. Carboplatin and Paclitaxel with Outcomes among Patients with Head and Neck Cancer Treated with Definitive Chemoradiation
    Location: Hall C
    Presenter: Sung Jun Ma, MD – The James Cancer Hospital & Solove Research Institute
  • 10:30 AM - 11:45 AM ET
    3686 - Association of the Number of Weekly Cisplatin Cycles with Outcomes among Patients with Head and Neck Cancer Treated with Definitive Chemoradiation
    Location: Hall C
    Presenter: Sung Jun Ma, MD – The James Cancer Hospital & Solove Research Institute
  • 10:30 AM - 11:45 AM ET
    3687 - Patterns of Palliative Radiotherapy Use in Botswana
    Location: Hall C
    Presenter: Emily MacDuffie, MD – University of Pennsylvania
  • 10:30 AM - 11:45 AM ET
    3688 - Association of Patient Comorbidities with Treatment Regret in Prostate Cancer: Results from a Population-Based Prospective Cohort
    Location: Hall C
    Presenter: Rahul Mali, MD, MD, MPH – University of Kansas Medical Center
  • 10:30 AM - 11:45 AM ET
    3689 - Nasal Cavity Malignancies Treated with Definitive Proton Therapy: A Single Institutions Experience
    Location: Hall C
    Presenter: Nikhil Mankuzhy, MD – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3690 - Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy
    Location: Hall C
    Presenter: César Márquez, MD, PhD – MD Anderson Cancer Center
  • 10:30 AM - 11:45 AM ET
    3691 - Trial in Progress: CTEP 10492, A Phase 1/1b Study of the AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Malcolm Mattes, MD – Rutgers Cancer Institute of New Jersey
  • 10:30 AM - 11:45 AM ET
    3692 - Treatment Outcome Priorities for Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) before and 12 Months after Primary (Chemo)Radiation (CRT/RT): Results from a Prospective Lo
    Location: Hall C
    Presenter: Lachlan McDowell, PhD, MBBS, FRANZCR – Princess Alexandra Hospital
  • 10:30 AM - 11:45 AM ET
    3693 - Sexual Health, Facial Appearance and Appearance Distress in Patients with Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC) Patients Undergoing (Chemo)Radiation (CRT/RT): Final Results fro
    Location: Hall C
    Presenter: Lachlan McDowell, PhD, MBBS, FRANZCR – Princess Alexandra Hospital
  • 10:30 AM - 11:45 AM ET
    3694 - Matched Cohort Analysis of Hypofractionated Adjuvant Radiation Therapy for Salivary Gland Cancer
    Location: Hall C
    Presenter: Brianna McGowan, BA – Lake Erie College of Osteopathic Medicine
  • 10:30 AM - 11:45 AM ET
    3695 - Spatially Fractionated Radiation Therapy for Bulky Head and Neck Malignancies: A Single Institution Experience
    Location: Hall C
    Presenter: Romy Megahed, MD – UAMS Radiation Oncology
  • 10:30 AM - 11:45 AM ET
    3696 - Advance Care Planning among Medicare Beneficiaries with Poor Prognosis Cancers
    Location: Hall C
    Presenter: Elie Mehanna, MD – Harvard Radiation Oncology Program
  • 10:30 AM - 11:45 AM ET
    3697 - Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy
    Location: Hall C
    Presenter: Benjamin Fronkier, BS – Argent Global Services
  • 10:30 AM - 11:45 AM ET
    3698 - Relationship between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated with Head and Neck Chemoradiotherapy
    Location: Hall C
    Presenter: Townes Mickel, MD – University of Texas Southwestern Medical Center
  • 10:30 AM - 11:45 AM ET
    3699 - Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis
    Location: Hall C
    Presenter: David Miller, MD, MS – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3700 - Gamma Knife Stereotactic Radiosurgery with a Reduced Peripheral Dose: Outcomes in Uveal Melanoma Patients
    Location: Hall C
    Presenter: Shubhendu Mishra, MD, MS – University of Minnesota Radiation Oncology Clinic University Campus
  • 10:30 AM - 11:45 AM ET
    3701 - Risk Factors for Developing Radiation Related Late Toxicities after Treatment for Head and Neck Cancers and Impact on Survival
    Location: Hall C
    Presenter: Shao Hui Huang, MS, RT – Princess Margaret Cancer Centre
  • 10:30 AM - 11:45 AM ET
    3702 - NCDB Analysis of Low-Risk HPV-Related H&N SCC of the Oropharynx Treated with Surgery: Can Adjuvant RT be Safely Omitted in Node Positive Patients?
    Location: Hall C
    Presenter: Christopher Morrison, MD, PhD – Banner Health
  • 10:30 AM - 11:45 AM ET
    3703 - Characterization of Radiation Response of Muscular Tissue in the Head and Neck Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
    Location: Hall C
    Presenter: Samuel Mulder, BS – MD Anderson Cancer Center
  • 10:30 AM - 11:45 AM ET
    3704 - Patterns of Failure in Resected Oral Cavity Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Adam Mutsaers, MD – London Health Sciences Centre
  • 10:30 AM - 11:45 AM ET
    3705 - Impact of Weekly Dietitian Intervention during On-Treatment Visits for Head and Neck Cancer Radiation
    Location: Hall C
    Presenter: Roger Neuberger, BS – Baylor College of Medicine
  • 10:30 AM - 11:45 AM ET
    3706 - Time and Financial Toxicity Implications during Consideration of Pembrolizumab Infusion Frequency
    Location: Hall C
    Presenter: Santosh Nori, BS, MPH – University of Michigan Medical School
  • 10:30 AM - 11:45 AM ET
    3707 - Stereotactic Body Radiation Therapy for Management of Locally Advanced Periorbital Tumors: Efficacy and Toxicity Profile
    Location: Hall C
    Presenter: Oluwatimileyin Ojo, MD – Northwell Health
  • 10:30 AM - 11:45 AM ET
    3708 - Validation of a Novel Predictive Radiation Treatment Score for Radiation Treatment Completion in Head and Neck Cancers
    Location: Hall C
    Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
  • 10:30 AM - 11:45 AM ET
    3709 - Evaluation of Nasopharyngeal Carcinoma Clinical Target Volume Automatic Delineation Based on Recurrence Regions in Radiotherapy
    Location: Hall C
    Presenter: Xiaomin Ou, MD – Fudan University Shanghai Cancer Center
  • 10:30 AM - 11:45 AM ET
    3710 - Cesium-131 Brachytherapy in Patients that are Not Candidates for Post-Operative External Beam Radiation Therapy: Interim Results of a Single Arm Prospective Study
    Location: Hall C
    Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
  • 10:30 AM - 11:45 AM ET
    3711 - Management of Oral Cavity Squamous Cell Carcinoma in Elderly Patients Using Diffusing Alpha-Emitter Radiation Therapy
    Location: Hall C
    Presenter: Aron Popovtzer, MD – Hadassah Medical Center
  • 10:30 AM - 11:45 AM ET
    3712 - Gantry-Based Pencil Beam Scanning (PBS) Proton Therapy for Uveal Melanoma: IMPT vs. Proton Arc Therapy
    Location: Hall C
    Presenter: Hang Qi, PhD – New York Proton Center
  • 10:30 AM - 11:45 AM ET
    3713 - The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation
    Location: Hall C
    Presenter: Guobin Qu
  • 10:30 AM - 11:45 AM ET
    3714 - Analysis of Avasopasem Manganese on Swallowing Outcomes for Oropharynx and Oral Cavity Patients Following Chemoradiation - A Single Institution Report
    Location: Hall C
    Presenter: Shri Rajan, MD – University of Iowa
  • 10:30 AM - 11:45 AM ET
    3715 - The Impact of Age and Tumor Volume on Volumetric Systemic Therapy Response in HPV-Positive Oropharyngeal HNSCC - A Pooled Analysis of Prospective Trials
    Location: Hall C
    Presenter: Greeshma Rajeev-Kumar, MD – University of Chicago Medicine
  • 10:30 AM - 11:45 AM ET
    3716 - Long Term Dysphagia Outcomes in Patients of Post Operative Oral Cavity Cancers Treated with Adjuvant Dysphagia Optimized vs. Standard Intensity Modulated Radiotherapy
    Location: Hall C
    Presenter: Madhup Rastogi, MD, MBBS – Dr.RMLIMS
  • 10:30 AM - 11:45 AM ET
    3717 - Carbon FootPrint Reduction with the Adoption of Hypofractionated Radiation Therapy in a Latin America Public Health Facility
    Location: Hall C
    Presenter: Jose Regis Neto, MD – Fundacao Assistencial da Paraiba (FAP)
  • 10:30 AM - 11:45 AM ET
    3718 - Tracking Circulating Tumor HPV DNA with Early Cessation of Radiotherapy in Oropharynx Cancer
    Location: Hall C
    Presenter: Zubir Rentiya, MD, MSc – University of Virginia
  • 10:30 AM - 11:45 AM ET
    3719 - Impact of Post-Operative Radiotherapy Neck Volume on Unstimulated Saliva Flow in Oral Cavity Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Claire Rooney, MB, ChB – Princess Margaret Cancer Center, University Health Network
  • 10:30 AM - 11:45 AM ET
    3720 - Development of a Prediction Model for Cisplatin Tolerability during Chemoradiation in Older Adults with Head and Neck Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Alexander Ruhle, MD – University of Leipzig, Medical Center
  • 10:30 AM - 11:45 AM ET
    3721 - Lessons Learned from an Epic Transformation of a Radiation Oncology Department in Guatemala: Keys to Success
    Location: Hall C
    Presenter: Edgar Aparicio Ruiz Furlan, MD – Liga Nacional Contra el Cancer
  • 10:30 AM - 11:45 AM ET
    3722 - Evaluating the Impact of Wildfires on Radiotherapy Compliance and Financial Costs: Insights from a Multi-Clinic Analysis
    Location: Hall C
    Presenter: Rachel Sabol, MD, PhD – UCSF
  • 10:30 AM - 11:45 AM ET
    3723 - Global Perspectives on Professional Practices and Training in Radiation Oncology: An International Survey
    Location: Hall C
    Presenter: Anneyuko Saito, MD, PhD – Juntendo University Faculty of Medicine
  • 10:30 AM - 11:45 AM ET
    3724 - Safe Deviation from the "5+5" Expansion Rule for the Delineation of Primary Tumor Clinical Target Volume (CTV-P) in Oropharyngeal Cancer: A Prospective Cohort Study
    Location: Hall C
    Presenter: Pierluigi Bonomo, MD – Azienda Ospedaliera Universitaria Careggi
  • 10:30 AM - 11:45 AM ET
    3725 - Global Interobserver Variations of Clinical Target Volume (CTV) Delineation among International Experts in Predefined Gross Tumor Volume (GTV) and Organs at Risk (OAR) Volumes in Head and Neck Cancer
    Location: Hall C
    Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3726 - Global Interobserver Variations of Clinical Target Volume (CTV) Delineation among International Experts in Given Standard Gross Tumor Volume (GTV) and Organs at Risk (OAR) Volumes in Lung Cancer
    Location: Hall C
    Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3727 - Global Interobserver Variations of Prescription and Plan Evaluation within Heterogeneous Clinical Target Volume (CTV) Delineations among International Experts in Head and Neck Cancers
    Location: Hall C
    Presenter: Ugur Selek, MD, FASTRO, Prof. – Koc University School of Medicine
  • 10:30 AM - 11:45 AM ET
    3728 - Assessing the Relationship of Radiation Treatment Breaks with the COVID-19 Pandemic and Overall Survival
    Location: Hall C
    Presenter: Aaron Seo, MD, PhD – MD Anderson Cancer Center
  • 10:30 AM - 11:45 AM ET
    3729 - Impact of Titanium Plate Reconstruction and Dental Amalgam on Risk of Osteoradionecrosis in Oral Cavity Cancer Patients Receiving Intensity Modulated Radiation Therapy
    Location: Hall C
    Presenter: Aishwarya Shah, MD – NYU Langone Health
  • 10:30 AM - 11:45 AM ET
    3731 - Heart of Care: Embracing Grief and Growth in Oncology and Palliative Medicine
    Location: Hall C
    Presenter: Nandan Shanbhag, MD – Tawam Hospital
  • 10:30 AM - 11:45 AM ET
    3732 - Interstitial Brachytherapy in Early-Stage Oral Cavity Carcinomas
    Location: Hall C
    Presenter: DN Sharma, MD
  • 10:30 AM - 11:45 AM ET
    3733 - Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
    Location: Hall C
    Presenter: sun shiran, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
  • 10:30 AM - 11:45 AM ET
    3734 - Long-Term Treatment Outcomes and Late Toxicity between Childhood and Adult Nasopharyngeal Carcinoma in the Era of IMRT
    Location: Hall C
    Presenter: sun shiran, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
  • 10:30 AM - 11:45 AM ET
    3735 - Kidney Cancer Patients Treatment Preferences for Localized Disease
    Location: Hall C
    Presenter: Samantha Sigurdson, MD – Hamilton Health Sciences
  • 10:30 AM - 11:45 AM ET
    3736 - Comparative Study to Assess the Quality of Life in Patients with Oral Cavity Cancer Treated with Adjuvant Radiation Therapy: Standard Intensity Modulated Radiotherapy vs. Dysphagia Optimized Intensity
    Location: Hall C
    Presenter: Pritanjali Singh, MBBS, DNB – All India Institute of Medical Sciences Patna
  • 10:30 AM - 11:45 AM ET
    3737 - Implications of the Primary Site and Additional Clinical Target Volume Margin in Target Volume Delineation for Intensity Modulated Radiation Therapy with Moderate Hypofractionation in Head Neck Cancer
    Location: Hall C
    Presenter: Shwetabh Sinha, MD, MBBS – ACTREC, TMC
  • 10:30 AM - 11:45 AM ET
    3738 - Endoscopic NBI Combined with MRI to Guide the Individualized Clinical Target Volume Delineation in Eccentric Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Yunrui Song, MBBS – Chongqing University Cancer Hospital
  • 10:30 AM - 11:45 AM ET
    3739 - Dose-Volume Predictors of Late Dysphagia after Definitive Radiotherapy in Larynx and Pharynx Cancer
    Location: Hall C
    Presenter: Ji Soo Sung, MD – Seoul National University Hospital
  • 10:30 AM - 11:45 AM ET
    3740 - Two Years of Clinical Experience with Accelerator-Based Boron Neutron Capture Therapy for Head and Neck Cancer
    Location: Hall C
    Presenter: Satoshi Takeno, MD, PhD – Osaka Medical and Pharmaceutical University
  • 10:30 AM - 11:45 AM ET
    3741 - A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup
    Location: Hall C
    Presenter: Wan Wei Tan, MS, RT – National Cancer Centre Singapore
  • 10:30 AM - 11:45 AM ET
    3742 - Boosting Antiproliferative Outcomes in Oral Cancer via Combined X-Ray and 6-n-butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.02,7]trideca-2,4,6,10-tetraene Therapy
    Location: Hall C
    Presenter: Jen-Yang Tang, MD, PhD – Kaohsiung Medical University Hospital
  • 10:30 AM - 11:45 AM ET
    3743 - A Prospective Cohort Study of Chemoradiotherapy with 1.8 Gy per Fraction for Hypopharyngeal Cancer
    Location: Hall C
    Presenter: Akito Taniguchi, MD – Mie University Hospital
  • 10:30 AM - 11:45 AM ET
    3744 - Predictive Decision Tree Modeling for Survival Outcomes in Metastatic Oropharyngeal Cancer Patients
    Location: Hall C
    Presenter: Abraham Arenas, MD – Baylor College of Medicine
  • 10:30 AM - 11:45 AM ET
    3745 - A Head and Neck Contour Grading System Provides an Objective Assessment of Radiation Oncology Resident Contouring Skills
    Location: Hall C
    Presenter: Diego Toesca, MD – Mayo Clinic Arizona
  • 10:30 AM - 11:45 AM ET
    3746 - Depth of Dose-Response for Patient-Reported Outcomes in Two Elective Neck Ee-Escalation Trials
    Location: Hall C
    Presenter: Anney Tuo, BA – UT Southwestern Medical Center
  • 10:30 AM - 11:45 AM ET
    3747 - Toxicity and Outcomes in Octogenarians Receiving Radiotherapy for Non-Melanoma Skin Cancer of the Head and Neck
    Location: Hall C
    Presenter: Adannia Ufondu, MD, BA – Cleveland Clinic
  • 10:30 AM - 11:45 AM ET
    3748 - Long-Term Tumor Outcomes in Patients with Head and Neck Cancer Treated with Avasopasem Manganese to Mitigate Severe Oral Mucositis: A Single Institution Retrospective Analysis
    Location: Hall C
    Presenter: Uwajachukwumma Uzomah, MD, MPH – University of Iowa Hospitals & Clinics
  • 10:30 AM - 11:45 AM ET
    3749 - Oral Squamous Cell Carcinoma Patients with Positive Cervical Nodes and Extracapsular Extension: A Real-World Data
    Location: Hall C
    Presenter: Rohit Vadgaonkar, MD – Homi Bhabha Cancer Hospital and Research Centre
  • 10:30 AM - 11:45 AM ET
    3750 - Advancing Image-Based Assessment of Long-Term Parotid-Gland Toxicity in Head and Neck Cancer Radiotherapy: Ultrasound Radiomics and Machine Learning
    Location: Hall C
    Presenter: Tian Liu, PhD – Icahn School of Medicine at Mount Sinai
  • 10:30 AM - 11:45 AM ET
    3751 - Radiotherapy in Addition to Immunotherapy-Based Systemic Therapy Delays Progression and Prolongs Survival in Recurrent Head and Neck Cancer
    Location: Hall C
    Presenter: Jingbo Wang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
  • 10:30 AM - 11:45 AM ET
    3752 - The Efficacy of PD-1 Inhibitor and Induction Chemotherapy Followed by Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinomas
    Location: Hall C
    Presenter: Jingbo Wang, MD – Cancer Institute and Hospital Chinese Acedemy of Medical Sciences
  • 10:30 AM - 11:45 AM ET
    3753 - Deep Transfer Learning and Dosiomics for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Li Wang, MD, PhD, MS – Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research
  • 10:30 AM - 11:45 AM ET
    3754 - Proton Therapy for Oral Cavity Cancers: A Dosimetric Comparison of Patients Enrolled on Trial of Hypofractionation
    Location: Hall C
    Presenter: Jessica Wilson, MD, PhD – Mayo Clinic Rochester
  • 10:30 AM - 11:45 AM ET
    3755 - Incidence and Outcome of Non-Malignant Pharyngeal Ulceration Following Definitive (Chemo)Radiation in Oropharyngeal Squamous Cell Carcinoma (SCC)
    Location: Hall C
    Presenter: Neil Woody, MD, MS – Cleveland Clinic
  • 10:30 AM - 11:45 AM ET
    3756 - Emergency Room (ER) Utilization Rate Among Patients with HPV related Oropharynx Cancer Undergoing Radiation De- Escalation
    Location: Hall C
    Presenter: Yingzhi Wu, MSN – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3757 - Individualized CTV Delineation Method for Nasopharyngeal Carcinoma Based on Safe Distance Expansion from Primary Tumor: A Preliminary Efficacy Report from a Prospective Observational Study
    Location: Hall C
    Presenter: Zheng Wu, MD
  • 10:30 AM - 11:45 AM ET
    3758 - Efficacy of Postoperative Radiotherapy Following Induction Immunochemotherapy and Surgical Resection in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Yi Xu, MD – National Cancer Center CAMS & PUMC
  • 10:30 AM - 11:45 AM ET
    3759 - MRI-Based Quantification of Intratumoral Heterogeneity in Locally Advanced Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Ge Yan, MD, PhD – Shanghai General Hospital, Shanghai Jiaotong University
  • 10:30 AM - 11:45 AM ET
    3760 - Anatomical and Dosimetric Variations during VMAT in Patients with Locally Advanced Nasopharyngeal Carcinoma after Induction Therapy: Implications for Adaptive Radiation Therapy
    Location: Hall C
    Presenter: Kunyu Yang, MD, DSc, PhD – Union Hospital Cancer Center, Tongji Medical College, HUST
  • 10:30 AM - 11:45 AM ET
    3761 - Optimal Target-Specific PTV Margins for Nasopharyngeal Carcinoma Radiotherapy with Daily FBCT Guidance
    Location: Hall C
    Presenter: Yu-Xian Yang, MD – Sun Yat-Sen University Cancer Center
  • 10:30 AM - 11:45 AM ET
    3762 - Taste Changes in Patients Receiving Head and Neck Radiation - Initial Analysis from a Prospective Study
    Location: Hall C
    Presenter: Sreenija Yarlagadda, MD – Miami Cancer Institute
  • 10:30 AM - 11:45 AM ET
    3764 - Improvements in Imaging Appear to Increase the Association between the Rates of Synchronous and Metachronous Metastases in Patients with Cancer
    Location: Hall C
    Presenter: Lawrence Marks, MD, FASTRO – UNC School of Medicine
  • 10:30 AM - 11:45 AM ET
    3765 - Multimodal Magnetic Resonance-Based Clinicoradiomics for Predicting Suspicious Lymph Node Metastasis in Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Jun Yin, MD – Sichuan Cancer Hospital and Institute
  • 10:30 AM - 11:45 AM ET
    3766 - Proton Therapy for Head/Neck Adenoid Cystic Carcinoma (ACC)
    Location: Hall C
    Presenter: Irini Youssef, MD – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3767 - Evaluation of the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 (ESMO-MCBS v.1.1) for the Treatment of Extracranial Oligometastatic Non-Small Cell Lung Cancer with Radiosurgery
    Location: Hall C
    Presenter: James Yu, MD, FASTRO, MHS – Connecticut Radiation Oncology, PC
  • 10:30 AM - 11:45 AM ET
    3768 - Outcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers
    Location: Hall C
    Presenter: Kaveh Zakeri, MD, MAS – Memorial Sloan Kettering Cancer Center
  • 10:30 AM - 11:45 AM ET
    3769 - Exploring the Role of Serum Uric Acid as a Potential Biomarker in Nasopharyngeal Carcinoma: A Retrospective Study Post-Adjuvant Chemotherapy
    Location: Hall C
    Presenter: Lei Zeng, MD – The Second Affiliated Hospital of Nanchang University
  • 10:30 AM - 11:45 AM ET
    3770 - Theoretical Research on Temporal Lobe Injury after Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma Using Machine Learning Approach and its Clinical Application
    Location: Hall C
    Presenter: Lei Zeng, MD – The Second Affiliated Hospital of Nanchang University
  • 10:30 AM - 11:45 AM ET
    3771 - The Efficacy and Safety Profile of PRaG "Therapy" in Geriatric Patients with Advanced Refractory Solid Malignant Tumors
    Location: Hall C
    Presenter: Xiangrong Zhao, MS – The Second Affiliated Hospital of Soochow University
  • 10:30 AM - 11:45 AM ET
    3772 - Dosimetric Benefit of Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Guan-Qun Zhou, MD, PhD – Sun Yat-Sen University Cancer Center